Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Nashville TN, St Louis MO, Cleveland OH, Detroit MI,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Nashville TN, Lexington KY, Atlanta GA, St Louis MO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
for
Angelman Syndrome
Location: Nashville TN, Atlanta GA, Cincinnati OH, Columbus OH,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 50
Code: NCT06914609
Phase3, Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Nashville TN, Tullahoma TN, Huntsville AL, Jackson TN,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure